Φορτώνει......
First-line treatment of advanced ALK-positive non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths, both within the US and worldwide. There have been major treatment advances in NSCLC over the past decade with the discovery of molecular drivers of NSCLC, which has ushered in an era of personalized medicine. There are...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Lung Cancer (Auckl) |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217519/ https://ncbi.nlm.nih.gov/pubmed/28210152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S63491 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|